Ami Kawamoto

7PUBLICATIONS
14CO-AUTHORS
Immunogenetics (incl. genetic immunology)Intensive careAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2026
Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract.

|Mar 16, 2026
Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis.

Akiko Tamura, Toshimitsu Fujii, Shun Fujiwara

|Dec 21, 2022
Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab.

Shun Fujiwara, Ami Kawamoto, Maiko Motobayashi

|Jun 14, 2022
Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.

Ami Kawamoto, Toshimitsu Fujii, Ryuji Mitani

|Sep 26, 2021
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' reply.

Kento Takenaka, Ami Kawamoto, Kazuo Ohtsuka

|Jul 29, 2021
Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.

Kento Takenaka, Ami Kawamoto, Shuji Hibiya

Pageof 2

Frequent Collaborators

5 joint publications

Kento Takenaka

5 joint publications

Ryuichi Okamoto

4 joint publications

Toshimitsu Fujii

4 joint publications

Kazuo Ohtsuka